Nephrotic syndrome with diffuse mesangial proliferative glomerulonephritis
ICD-10 N04.3 is a billable code used to indicate a diagnosis of nephrotic syndrome with diffuse mesangial proliferative glomerulonephritis.
Nephrotic syndrome is characterized by a triad of symptoms: significant proteinuria, hypoalbuminemia, and edema. When associated with diffuse mesangial proliferative glomerulonephritis, it indicates a specific type of kidney inflammation affecting the mesangial cells. This condition often presents with heavy proteinuria, which can exceed 3.5 grams per day, leading to low serum albumin levels and resultant edema. Patients may also exhibit hematuria, hypertension, and renal insufficiency. A renal biopsy typically reveals diffuse mesangial proliferation, which is a hallmark of this condition. The etiology can be idiopathic or secondary to systemic diseases such as lupus or infections. Management often involves corticosteroids and immunosuppressive agents, alongside supportive care for edema and hypertension. Regular monitoring of renal function and proteinuria is essential for assessing treatment efficacy and disease progression.
Detailed clinical notes on symptoms, lab results, and treatment plans.
Patients presenting with edema, proteinuria, and renal dysfunction.
Ensure accurate recording of renal function tests and biopsy findings.
Comprehensive pathology reports detailing biopsy findings.
Biopsy evaluations for suspected glomerulonephritis.
Clear correlation between pathology findings and clinical diagnosis.
Used when a renal biopsy is performed to confirm diagnosis.
Pathology report and clinical notes detailing indications for biopsy.
Ensure nephrology and pathology notes are aligned.
The primary symptom of nephrotic syndrome is significant proteinuria, often accompanied by edema and low serum albumin levels.
